发明名称 |
Vascular occlusion solid-phase agent with immobilised platelet binding agent |
摘要 |
<p>Disclosed is a composition for inducing thrombus formation in vivo comprising: a solid phase agent selected from a specified group, capable of binding a platelet specific component; and a platelet specific component, chosen from a specified group including von Willebrand Factor (VWF), where, upon delivery to the target vasculature it binds platelets onto the solid-phase agent and induces platelet activation. The disclosure allows for the purposeful induction of thrombosis for use in hyperplastic or neoplastic vasculature, arterio-venous malformations, or hemorrhaging vasculature. Of particular interest is the reduction in blood flow to cancer cells.</p> |
申请公布号 |
NZ532243(A) |
申请公布日期 |
2006.03.31 |
申请号 |
NZ20020532243 |
申请日期 |
2002.09.11 |
申请人 |
VIREXX MEDICAL CORPORATION |
发明人 |
STEWART, MICHAEL W;PERSON, ROLAND HENRYK;NOUJAIM, ANTOINE A |
分类号 |
A61K9/00;A61B17/12;A61F2/82;A61K9/16;A61K31/16;A61K38/36;A61K38/37;A61K38/43;A61K45/00;A61K47/48;A61L24/10;A61L27/00;A61L31/00;A61L31/04;A61L31/16;A61P35/00;(IPC1-7):A61K9/00 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|